Skip to main content
. 2017 Dec 11;192(1):95–103. doi: 10.1111/cei.13082

Table 2.

The correlations between the levels of sMer/sTyro3 and clinical features in rheumatoid arthritis (RA) patients

sMer sTyro3
Features r P‐value r P‐value
Age (years) 0·094 0·118 0·044 0·466
WBC 0·027 0·653 0·192 0·001
RBC −0·091 0·183 0·023 0·726
Hb −0·114 0·095 0·008 0·899
PLT 0·121 0·078 0·063 0·340
IgA 0·029 0·634 0·066 0·276
IgM 0·063 0·299 0·163 0·007
IgG 0·003 0·963 0·080 0·186
ESR 0·093 0·125 −0·007 0·912
CRP 0·125 0·064 0·028 0·639
RF 0·041 0·494 0·133 0·026
Anti‐CCP antibody −0·076 0·230 0·018 0·781
SJC 0·092 0·127 0·159 0·008
TJC 0·081 0·181 0·226 0·001

Anti‐CCP antibody = anti‐cyclic citrullinated peptide antibody; CRP = C‐reactive protein; ESR = erythrocyte sedimentation rate; Hb = haemoglobin; Ig = immunoglobulin; PLT = platelet; RBC = red blood cell; RF = rheumatoid factor; SJC = swollen joint counts; sMer = soluble Mer; sTyro3 = soluble Tyro3; TJC = tender joint counts; WBC = white blood cell. Bold fonts highlights the significant correlation between clinical parameters and sTyro3 levels.